m6A genotypes and prognostic signature for assessing the prognosis of patients with acute myeloid leukemia
Abstract Background N6-methyladenosine (m6A) has been confirmed to function critically in acute myeloid leukemia (AML) progression. Hitherto, the subtyping and prognostic predictive significance of m6A-correlated genes in AML is unclear. Method From The Cancer Genome Atlas (TCGA-LAML), Therapeutical...
Saved in:
Main Authors: | Caizhu Fu (Author), Ruirui Kou (Author), Jie Meng (Author), Duanfeng Jiang (Author), Ruilan Zhong (Author), Min Dong (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comprehensive Analysis of a Ferroptosis Pattern and Associated Prognostic Signature in Acute Myeloid Leukemia
by: Zelong Cui, et al.
Published: (2022) -
Metastasis Related Epithelial-Mesenchymal Transition Signature Predicts Prognosis and Response to Chemotherapy in Acute Myeloid Leukemia
by: Qu S, et al.
Published: (2023) -
The pyroptosis-related gene signature predicts prognosis and reveals characterization of the tumor immune microenvironment in acute myeloid leukemia
by: Tao Zhou, et al.
Published: (2022) -
MMP9-Associated Tumor Stem Cells, CCL1-Silenced Dendritic Cells, and Cytokine-Induced Killer Cells Have a Remarkable Therapeutic Efficacy for Acute Myeloid Leukemia by Activating T Cells
by: Min Dong, et al.
Published: (2023) -
Development and validation of GMI signature based random survival forest prognosis model to predict clinical outcome in acute myeloid leukemia
by: Mingguang Shi, et al.
Published: (2019)